Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2019 1
2020 1
2021 7
2022 1
2023 3
2024 0

Text availability

Article attribute

Article type

Publication date

Search Results

13 results

Results by year

Filters applied: . Clear all
Page 1
CD8+ T cells maintain killing of MHC-I-negative tumor cells through the NKG2D-NKG2DL axis.
Lerner EC, Woroniecka KI, D'Anniballe VM, Wilkinson DS, Mohan AA, Lorrey SJ, Waibl-Polania J, Wachsmuth LP, Miggelbrink AM, Jackson JD, Cui X, Raj JA, Tomaszewski WH, Cook SL, Sampson JH, Patel AP, Khasraw M, Gunn MD, Fecci PE. Lerner EC, et al. Among authors: mohan aa. Nat Cancer. 2023 Sep;4(9):1258-1272. doi: 10.1038/s43018-023-00600-4. Epub 2023 Aug 3. Nat Cancer. 2023. PMID: 37537301 Free PMC article.
Targeting Immunometabolism in Glioblastoma.
Mohan AA, Tomaszewski WH, Haskell-Mendoza AP, Hotchkiss KM, Singh K, Reedy JL, Fecci PE, Sampson JH, Khasraw M. Mohan AA, et al. Front Oncol. 2021 Jun 16;11:696402. doi: 10.3389/fonc.2021.696402. eCollection 2021. Front Oncol. 2021. PMID: 34222022 Free PMC article. Review.
Enhancing T Cell Chemotaxis and Infiltration in Glioblastoma.
Singh K, Hotchkiss KM, Patel KK, Wilkinson DS, Mohan AA, Cook SL, Sampson JH. Singh K, et al. Among authors: mohan aa. Cancers (Basel). 2021 Oct 26;13(21):5367. doi: 10.3390/cancers13215367. Cancers (Basel). 2021. PMID: 34771532 Free PMC article. Review.
Systemic inhibition of PTPN22 augments anticancer immunity.
Ho WJ, Croessmann S, Lin J, Phyo ZH, Charmsaz S, Danilova L, Mohan AA, Gross NE, Chen F, Dong J, Aggarwal D, Bai Y, Wang J, He J, Leatherman JM, Yarchoan M, Armstrong TD, Zaidi N, Fertig EJ, Denny JC, Park BH, Zhang ZY, Jaffee EM. Ho WJ, et al. Among authors: mohan aa. J Clin Invest. 2021 Jul 20;131(17):e146950. doi: 10.1172/JCI146950. Online ahead of print. J Clin Invest. 2021. PMID: 34283806 Free PMC article.
Multicenter randomized phase II trial of atezolizumab with or without cobimetinib in biliary tract cancers.
Yarchoan M, Cope L, Ruggieri AN, Anders RA, Noonan AM, Goff LW, Goyal L, Lacy J, Li D, Patel AK, He AR, Abou-Alfa GK, Spencer K, Kim EJ, Davis SL, McRee AJ, Kunk PR, Goyal S, Liu Y, Dennison L, Xavier S, Mohan AA, Zhu Q, Wang-Gillam A, Poklepovic A, Chen HX, Sharon E, Lesinski GB, Azad NS. Yarchoan M, et al. Among authors: mohan aa. J Clin Invest. 2021 Dec 15;131(24):e152670. doi: 10.1172/JCI152670. J Clin Invest. 2021. PMID: 34907910 Free PMC article. Clinical Trial.
For whom the T cells troll? Bispecific T-cell engagers in glioblastoma.
Singh K, Hotchkiss KM, Mohan AA, Reedy JL, Sampson JH, Khasraw M. Singh K, et al. Among authors: mohan aa. J Immunother Cancer. 2021 Nov;9(11):e003679. doi: 10.1136/jitc-2021-003679. J Immunother Cancer. 2021. PMID: 34795007 Free PMC article. Review.
Development, Practice Patterns, and Early Clinical Outcomes of a Multidisciplinary Liver Cancer Clinic.
Jia AY, Popovic A, Mohan AA, Zorzi J, Griffith P, Kim AK, Anders RA, Burkhart RA, Lafaro K, Georgiades C, Azad NS, Liddell RP, Baretti M, Kamel IR, Narang A, Yarchoan M, Meyer J. Jia AY, et al. Among authors: mohan aa. Cancer Control. 2021 Jan-Dec;28:10732748211009945. doi: 10.1177/10732748211009945. Cancer Control. 2021. PMID: 33882707 Free PMC article.
13 results